Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for inflammation and endothelial function in peripheral arterial disease
NL-OMON23404Active, not recruiting
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of doxycycline in arteriosclerosis obliterans and atherosclerosis (2 arms), sponsored by none. Primary endpoint: Endothelial function. Started Jan 2006; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
arteriosclerosis obliteransatherosclerosis
Beyond the preview
Go deeper on NL-OMON23404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23404.